Clinical Trial Update: Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating systemic therapy with or without upfront transarterial embolization for inoperable liver metastases from neuroendocrine tumors was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Neuroendocrine Tumors | Phase 3 | Status: TERMINATED